Video | 15 February 2020 A recipe for an affordable medicine goes bad 1 min RESEARCH AND DEVELOPMENT Governments use taxpayer money to try to get Big Pharma to develop medicines we need. These incentives are supposed to be the ingredients for an affordable medicine. Watch the video to see how it really turns out. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products? Technical brief | 11 November 2022 Research and development MSF Clinical Trial Transparency Policy Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products? Blog Blog | 05 October 2022 Research and development South Africa can and must demand better deals for drug clinical trials — lives depend on it Events Events Research and development Roundtable series: How can disclosing clinical trial costs increase access to medical products 2 min Load More
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min
Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products?
Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products?
Blog Blog | 05 October 2022 Research and development South Africa can and must demand better deals for drug clinical trials — lives depend on it
Events Events Research and development Roundtable series: How can disclosing clinical trial costs increase access to medical products 2 min
